Thomas Englese, MBA

Executive Vice President, Commercial Operations

Mr. Englese has more than 20 years of experience in domestic and international commercial functions at biopharmaceutical companies across a breadth of therapeutic areas such as ADHD, pain management, cardiology, liver disease, anesthesia and critical care.

Prior to joining Tonix Pharmaceuticals, he was the Chief Commercial Officer at Tris Pharma where he was responsible for the branded ADHD portfolio including all aspects of commercialization for their four branded stimulants and the launch preparation for their newly approved branded non stimulant. Mr. Englese was also the Chief Commercial Officer at Aziyo Biologics, now Elutia, where he oversaw multiple business units, profitably negotiated commercial partnerships with distinguished organizations and was a key leader of the company’s successful IPO team. Earlier in his career, he held various positions at Mallinckrodt (formerly Ikaria Inc.), where he was responsible for the North America franchise of several key products, as well as at Baxter, where he spent six years managing business operations and global analytics. Mr. Englese earned his Bachelor of Science in Marketing from Villanova University and his Master of Business Administration in Finance from Pennsylvania State University.